MEDIROM Healthcare Technologies Inc. Receives Notification from Nasdaq Related to Delayed Filing of Annual Report
18 Maio 2022 - 5:15PM
MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a leading
holistic health services provider in Japan (the “Company”), today
announced that on May 17, 2022, as a result of its failure to
timely file with the U.S. Securities and Exchange Commission (the
“SEC”) its Annual Report on Form 20-F for the year ended December
31, 2021 (the “Form 20-F”), it received a notice from The Nasdaq
Stock Market LLC (“Nasdaq”) stating that the Company was not in
compliance with the periodic filing requirements for continued
listing set forth in Nasdaq Listing Rule 5250(c)(1). Nasdaq listing
rules provide the Company with 60 calendar days from the date of
the notice to submit a plan to regain compliance. The Company
intends to file the Form 20-F prior to the expiration of the 60-day
period.
The Nasdaq notice has no immediate effect on the
listing or trading of the Company’s American Depositary Shares
representing its common shares on Nasdaq. As previously disclosed
by the Company in its Form 12b-25 filed with the SEC on April 28,
2022, the Company was unable to file its Form 20-F by its original
deadline without unreasonable effort or expense. The Company is
working diligently on its plan to regain compliance and file its
Form 20-F as soon as practicable.
About MEDIROM Healthcare Technologies
Inc.
MEDIROM, a holistic healthcare company, operates
310 (as of March 31, 2022) relaxation salons across Japan,
Re.Ra.Ku®, being its leading brand, and provides healthcare
services. In 2015, MEDIROM entered the health tech business, and
launched new healthcare programs using on-demand training app
called “Lav®”, which is developed by the company. MEDIROM also
entered the device business in 2020 and is developing a smart
tracker “MOTHER Bracelet™” (formerly known as “MOTHER Tracker®”).
MEDIROM hopes that its diverse health related services and products
offering will help it collect and manage healthcare data from users
and customers and enable it to become a leader in big data in the
healthcare industry. For more information, please visit
https://medirom.co.jp/en.
Forward-Looking
StatementsCertain statements in this press release are
forward-looking statements for purposes of the safe harbor
provisions under the U.S. Private Securities Litigation Reform Act
of 1995. Forward-looking statements may include estimates or
expectations about the Company’s possible or assumed operational
results, financial condition, business strategies and plans, market
opportunities, competitive position, industry environment, and
potential growth opportunities. In some cases, forward-looking
statements can be identified by terms such as “may,” “will,”
“should,” “design,” “target,” “aim,” “hope,” “expect,” “could,”
“intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,”
“predict,” “project,” “potential,” “goal,” or other words that
convey the uncertainty of future events or outcomes. These
statements relate to future events or to the Company’s future
financial performance, and involve known and unknown risks,
uncertainties and other factors that may cause the Company’s actual
results, levels of activity, performance, or achievements to be
materially different from any future results, levels of activity,
performance or achievements expressed or implied by these
forward-looking statements. There can be no assurance that Nasdaq
will accept the Company’s plan to regain compliance or that the
Company will be able to regain compliance within any extension
period granted by Nasdaq. You should not place undue reliance on
forward-looking statements since they involve known and unknown
risks, uncertainties and other factors which are, in some cases,
beyond the Company’s control and which could, and likely will,
materially affect actual results, levels of activity, performance
or achievements. Any forward-looking statement reflects the
Company’s current views with respect to future events and is
subject to these and other risks, uncertainties and assumptions
relating to the Company’s operations, results of operations, growth
strategy and liquidity. The Company assumes no obligation to
publicly update or revise these forward-looking statements for any
reason, or to update the reasons actual results could differ
materially from those anticipated in these forward-looking
statements, even if new information becomes available in the
future.
Contacts:
Investor Relations Team
ir@medirom.co.jp
or
U.S. Investor Contact
Robert Blum, Joe Diaz, Joe Dorame
Lytham Partners, LLC
602-889-9700
MRM@lythampartners.com
MEDIROM Healthcare Techn... (NASDAQ:MRM)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
MEDIROM Healthcare Techn... (NASDAQ:MRM)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024